Key result
Chronic hyperprolactinemia is linked to impaired LV diastolic filling and reduced walking distance.
Why the study?
Little information is available regarding the cardiovascular consequences of hyperprolactinemia in humans, despite known myocardial prolactin-binding activity and contractility-enhancing effects in animal models.
Does chronic hyperprolactinemia impair left ventricular structure, systolic function, or diastolic function in patients with isolated prolactin-secreting pituitary adenoma compared to matched controls?
Case-Control (n=48)
Single-blind (echocardiography investigator blinded to subject group)
No
Does chronic hyperprolactinemia impair left ventricular structure, systolic function, or diastolic function in patients with isolated prolactin-secreting pituitary adenoma compared to matched controls?
Chronic untreated hyperprolactinemia is associated with subclinical impairment of left ventricular diastolic relaxation and reduced exercise capacity—particularly in females—despite preserved LV morphology and systolic function.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for diastolic impairment in hyperprolactinemia; prospective studies needed to confirm causality and reversibility.
Despite the myocardial prolactin (PRL) binding activity and the known effect of enhancing contractility in the isolated rat heart, little information is available concerning the cardiovascular consequences of hyperprolactinemia in humans. To elucidate the effects of chronic hyperprolactinemia on cardiac structure and function, twenty-four patients with isolated PRL-secreting adenoma and twenty-four controls underwent a complete mono- and two-dimensional Doppler-echocardiography. Blood pressure and heart rate were similar in the two groups, and no significant differences were observed as to left ventricular (LV) geometry between patients and controls. Resting LV systolic function was normal in patients with hyperprolactinemia, as shown by similar values of fractional shortening and cardiac output. Conversely, hyperprolactinemic patients exhibited a slight impairment of LV diastolic filling, as demonstrated by the prolongation of the isovolumetric relaxation time and the increase of the atrial filling wave of mitral Doppler velocimetry (58 ± 13 vs. 47 ± 8 cm/s, p < 0.05) with a subgroup of females (16%) having a clear diastolic dysfunction, and a worse exercise capacity (6 min walking test 452 ± 70 vs. 524 ± 56; p < 0.05). In conclusion, hyperprolactinemia in humans may be associated with a slight impairment of diastolic function, with an overt diastolic dysfunction in a subgroup of females which correlated with poorer exercise performance, in the absence of significant abnormalities of LV structure and systolic function.
No takes yet. Share an insight, caveat, or question.
Arcopinto et al. (2023) conducted a case-control in Chronic hyperprolactinemia (isolated PRL-secreting adenoma) (n=48). Chronic hyperprolactinemia (isolated PRL-secreting adenoma) vs. Age- and sex-matched healthy control subjects was evaluated on Left ventricular diastolic filling (mitral Doppler atrial filling wave [A wave] velocity, cm/s) (p=<0.05). Chronic hyperprolactinemia was associated with impaired left ventricular diastolic filling and reduced walking distance.
Synapse has enriched 10 related papers. Consider them for comparative context: